Twitter Facebook LinkedIn YouTube

Supreme Pharmaceuticals, (TSXV: FIRE) completed its first sale of dried cannabis to Aurora Cannabis

Video Platform Video Management Video Solutions Video Player

Aurora Cannabis, one of Canada’s leading licensed producers, will sell cannabis procured from 7ACRES to its medical cannabis patients, with a producer’s mark specifying the cannabis as “SunGrown by 7ACRES”.

Additional Information:

Company: Supreme Pharmaceuticals
Website: http://www.supreme.ca
Stock Symbol: TSXV: FIRE
Date Published: Sep 6, 2017
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch media

Supreme Pharmaceuticals, (TSXV: FIRE) completed its first sale of dried cannabis to Aurora Cannabis.

Aurora Cannabis (TSX:ACB), one of Canada’s leading licensed producers, will sell cannabis procured from 7ACRES to its medical cannabis patients, with a producer’s mark specifying the cannabis as “SunGrown by 7ACRES”.

7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Greenhouse facility located in Kincardine, Ontario.

It is the largest facility of its kind to grow with advanced HVAC and C02 enrichment using the full-spectrum sun, rather than the limited-spectrum lamps used by many ‘hybrid’ growers.

John Fowler, President and CEO, stated: “Our team works tirelessly to achieve our goal of producing craft quality cannabis at scale. We chose Aurora as our primary retail partner due to Aurora’s strong brand and commitment to quality. The 7ACRES producer’s mark aligns with the Aurora Certified Program, which provides patients a transparent curated experience. We look forward to developing a long-term relationship with Aurora and consider this just the first step."

Since it commenced sales of dried cannabis in 2016, Aurora has grown its patient population to over 19,000 registered patients by focusing on quality cannabis, a premium user experience and a transparent quality assurance program.

Prior to completing the transaction, 7ACRES underwent a detailed quality inspection by Aurora including an on-site audit and multiple laboratory tests to ensure the cannabis procured met the Aurora Standard for quality and transparency.

The company started trading on the TSX Venture Exchange on June 6, 2017, moving from the Canadian Securities Exchange.

The shares are trading at $1.20, and with 188 million outstanding, the company is capitalized at $226 million.

For more information, please visit the company’s websites, www.supreme.ca and www.7acres.com, contact investor relations at 416-630-7272 or email info@supreme.ca.

I’m Samantha Deutscher for Investmentpitch media